Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
30 studies found for:    " May 11, 2011":" June 10, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" May 11, 2011":" June 10, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
Conditions: Patient Adherence;   HIV
Intervention: Behavioral: SMS Text Message Reminder
2 Active, not recruiting A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
Conditions: Human Immunodeficiency Virus (HIV) Infections;   Acquired Immunodeficiency Syndrome (AIDS) Virus
Interventions: Drug: Darunavir;   Drug: Ritonavir
3 Active, not recruiting
Has Results
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Stribild;   Drug: COBI;   Drug: ATV;   Drug: DRV;   Drug: NRTI
4 Completed A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus (HIV) Infection
Intervention: Drug: Etravirine
5 Active, not recruiting Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
Condition: HIV Positive
Intervention: Drug: Vorinostat
6 Completed Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
Condition: HIV-Associated Lipodystrophy Syndrome
Intervention:
7 Completed Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Ring;   Drug: Maraviroc Vaginal Ring;   Other: Placebo Vaginal Ring;   Drug: Dapivirine-Maraviroc Vaginal Ring
8 Completed HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence
Conditions: Acute HIV Infection;   Acquired Immunodeficiency Syndrome;   Medication Adherence
Intervention: Behavioral: Advanced Adherence Counseling (AdvAdh)
9 Recruiting Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)
Condition: HIV Infection
Interventions: Drug: Maraviroc, Darunavir/r;   Drug: current antiretroviral therapy with 3 drugs
10 Completed Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients
Condition: HIV Infection
Intervention:
11 Completed A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: DNA.HIVA;   Biological: MVA.HIVA
12 Completed Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice
Condition: HIV Infections
Intervention: Drug: darunavir/ritonavir plus background regimen
13 Recruiting A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: Trans-theoretical Process of Change Model-self;   Behavioral: Trans-theoretical Process of Change Model - interviewer
14 Active, not recruiting Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
Conditions: Visceral Leishmaniosis;   HIV-infection/Aids
Intervention: Drug: Pentamidine
15 Completed
Has Results
Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)
Condition: Human Immunodeficiency Virus Infection
Intervention:
16 Completed Dolutegravir Renal Impairment Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Dolutegravir 50 mg
17 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
18 Completed Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: BI 201335
19 Terminated Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)
Condition: HIV-1 Infection
Interventions: Drug: MK-1972;   Drug: Placebo to MK-1972
20 Unknown  Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia
Conditions: HIV Risk Behaviors;   Heroin Injection;   Retention in Methadone Treatment
Interventions: Behavioral: Behavioral Drug and Risk Counseling (BDRC);   Behavioral: methadone maintenance treatment

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years